Massachusetts Financial Services
CAI

Massachusetts Financial Services’s Caris Life Sciences CAI Stock Holding History

Massachusetts Financial Services’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Sell
27,314
-240,636
-90% -$4.31M ﹤0.01% 953
2026
Q1 		$4.79M Sell
267,950
-673,689
-72% -$14.7M ﹤0.01% 759
2025
Q4 		$25.4M Sell
941,639
-29,691
-3% -$836K 0.01% 604
2025
Q3 		$29.4M Sell
971,330
-78,398
-7% -$2.5M 0.01% 572
2025
Q2 		$28M Buy
+1,049,728
New +$28.3M 0.01% 566

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services's CAI Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Caris Life Sciences (CAI) stake by 90% in Q2 2026, selling an estimated $4.31M and leaving 27,314 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Massachusetts Financial Services first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $29.4M in Q3 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Massachusetts Financial Services held 27,314 shares of Caris Life Sciences worth $487K as of Q2 2026.
  • Massachusetts Financial Services sold 240,636 Caris Life Sciences shares in Q2 2026, an estimated $4.31M.
  • Caris Life Sciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #953 holding.
  • Massachusetts Financial Services first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Massachusetts Financial Services's Caris Life Sciences position peaked at $29.4M in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.